Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Phreesia stock last closed at $23.25, down 3% from the previous day, and has increased 3.75% in one year. It has overperformed other stocks in the Health Information Services industry by 0.74 percentage points. Phreesia stock is currently +36.2% from its 52-week low of $17.07, and -23.85% from its 52-week high of $30.53.
At the moment, there are 58.77M PHR shares outstanding. The market cap of PHR is $1.37B. In the last 24 hours, 410,034 PHR shares were traded.
How to Buy Phreesia Stock
Not sure how to invest in Phreesia stock? Here's how.
Figure out where to buy Phreesia stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Phreesia stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Put funds into your investment account: Select your payment method and add your info.
Analyze Phreesia stock: The Phreesia ticker symbol is PHR. Is Phreesia stock a good investment? Should you buy shares of PHR? How do PHR's underlying business fundamentals look? Do top analysts think Phreesia is a good buy? Why has PHR's stock price moved recently? (Hint: Our stock research tools can help you understand if PHR is a good stock to buy).
Execute your PHR purchase: Decide if you will purchase PHR shares at the current market price or use a limit order to purchase PHR shares at a specific price.
Track your investment in PHR: Create a watchlist to track your investment in Phreesia stock.
Step 1: Figure out where to buy Phreesia stock
You need an online brokerage account in order to access the NYSE market and buy PHR stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to buy PHR stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Phreesia stock
Once you have identified the best place to buy Phreesia stock, it's important to research their stock prior to buying, so you actually wrap your head around the risk and opportunity.
Phreesia Numbers
PHR Price
$23.25
1w %
-2.39%
1y %
3.75%
5y %
3.1%
P/E
-22.79x
P/B
5.16x
P/S
3.19x
PEG
N/A
Revenue
$419.81M
Earnings
-$58.53M
Fore. Rev. Growth
12.28%
Fore. Earn. Growth
N/A
Market Cap
$1.37B
Next Earnings
May 28, 2025
Next Dividend
N/A
PHR Fundamentals
WallStreetZen was created to help everyday investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on PHR's stock page.
What is the fair value of PHR stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge PHR's intrinsic value.
Using relative valuations measures:
PHR may be overvalued based on its P/B ratio of 5.16x, relative to Health Information Services industry P/B ratio of 3.29x
You can access additional valuation research on PHR's stock here.
PHR Financial Health Overview
Pros:
Total PHR debt is lower than 5 years ago, relative to shareholder equity.
PHR profit margin has gone up from -38.4% to -13.9% in the past year.
There are more short-term assets than long-term liabilities on the PHR balance sheet.
PHR's operating cash flow of $32.38M allows it to safely service it's debt of $17.80M.
There are more short-term assets than short-term liabilities on the PHR balance sheet.
Cons:
PHR has a relatively high debt to equity ratio of 0.47.
PHR earnings of -$55.81M is not sufficient to cover its interest payments.
Is it a good time to buy PHR stock, according to Wall Street analysts?
Out of 10 Equities analysts who research PHR, the consensus analyst rating on Phreesia is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest PHR Analyst Forecasts
Daniel Grosslight, a bottom 22% analyst from Citigroup maintains PHR with a strong buy rating and raises their PHR price target from $31.00 to $35.00, on Jan 10, 2025.
Sean Dodge, a top 19% analyst from RBC Capital upgrades PHR to a buy rating and raises their PHR price target from $24.00 to $32.00, on Jan 8, 2025.
Jailendra Singh, a bottom 2% analyst from Truist Securities maintains PHR with a strong buy rating and raises their PHR price target from $31.00 to $34.00, on Dec 11, 2024.
Joseph Vruwink, a bottom 32% analyst from Baird maintains PHR with a buy rating and lowers their PHR price target from $34.00 to $30.00, on Dec 11, 2024.
Aaron Kimson, a bottom 12% analyst from JMP Securities reiterates PHR with a buy rating and maintains their PHR price target from $30.00 to $30.00, on Dec 10, 2024.
Last year, PHR revenue was $419.81M. During the past 5 year, PHR's revenue has grown by 27.46% per year. This was faster than the Health Information Services industry average of 22.41%.
No, Phreesia doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your PHR purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are generally the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given price, use a limit order.
Hit the Open Trade button and eToro will execute your order.
If you want additional help investing in stocks on eToro, click the helpful video below:
As of Apr 21, 2025, it costs $23.25 to buy one share of Phreesia stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.43 shares of PHR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.